These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 6335980)

  • 1. Studies on peptides. CXXIV. Solution synthesis of the hentetracontapeptide amide corresponding to the entire amino acid sequence of human corticotropin releasing factor (hCRF).
    Fujii N; Nomizu M; Akaji K; Watanabe K; Shimokura M; Katakura S; Yajima H; Shono F; Tsuda M; Yoshitake A
    Chem Pharm Bull (Tokyo); 1984 Dec; 32(12):4797-805. PubMed ID: 6335980
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on peptides. CXXIII. Preparations of nine peptide fragments for the synthesis of human corticotropin releasing factor (hCRF).
    Fujii N; Nomizu M; Akaji K; Shimokura M; Katakura S; Yajima H
    Chem Pharm Bull (Tokyo); 1984 Dec; 32(12):4786-96. PubMed ID: 6335979
    [No Abstract]   [Full Text] [Related]  

  • 3. An optimized solid phase synthesis strategy--including on-resin lactamization--of astressin, its retro-, inverso-, and retro-inverso isomers as corticotropin releasing factor antagonists.
    Rijkers DT; den Hartog JA; Liskamp RM
    Biopolymers; 2002 Feb; 63(2):141-9. PubMed ID: 11787002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Astressin analogues (corticotropin-releasing factor antagonists) with extended duration of action in the rat.
    Rivier J; Gulyas J; Corrigan A; Martinez V; Craig AG; Taché Y; Vale W; Rivier C
    J Med Chem; 1998 Dec; 41(25):5012-9. PubMed ID: 9836619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation, structural elucidation and synthesis of a tetradecapeptide with in vitro ACTH-releasing activity corresponding to residues 33-46 of the alpha-chain of porcine hemoglobin.
    Schally AV; Huang WY; Redding TW; Arimura A; Coy DH; Chihara K; Chang RC; Raymond V; Labrie F
    Biochem Biophys Res Commun; 1978 May; 82(2):582-8. PubMed ID: 208567
    [No Abstract]   [Full Text] [Related]  

  • 6. Constrained corticotropin-releasing factor (CRF) agonists and antagonists with i-(i+3) Glu-Xaa-DXbb-Lys bridges.
    Koerber SC; Gulyas J; Lahrichi SL; Corrigan A; Craig AG; Rivier C; Vale W; Rivier J
    J Med Chem; 1998 Dec; 41(25):5002-11. PubMed ID: 9836618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Constrained corticotropin releasing factor antagonists (astressin analogues) with long duration of action in the rat.
    Rivier JE; Kirby DA; Lahrichi SL; Corrigan A; Vale WW; Rivier CL
    J Med Chem; 1999 Aug; 42(16):3175-82. PubMed ID: 10447963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding differences of human and amphibian corticotropin-releasing factor type 1 (CRF(1)) receptors: identification of amino acids mediating high-affinity astressin binding and functional antagonism.
    Dautzenberg FM; Wille S
    Regul Pept; 2004 May; 118(3):165-73. PubMed ID: 15003833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on peptides. CLIII. Application of the hard-acid deprotecting procedure to the synthesis of ovine corticotropin releasing factor (oCRF).
    Akaji K; Nomizu M; Watanabe K; Funakoshi S; Imura H; Tsukada T; Fukata J; Nakamuta H; Koida M; Fujii N
    Chem Pharm Bull (Tokyo); 1987 Sep; 35(9):3859-65. PubMed ID: 3501735
    [No Abstract]   [Full Text] [Related]  

  • 10. Corticotropin releasing factor (CRF) agonists with reduced amide bonds and Ser7 substitutions.
    Cervini L; Theobald P; Corrigan A; Craig AG; Rivier C; Vale W; Rivier J
    J Med Chem; 1999 Feb; 42(4):761-8. PubMed ID: 10052982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological activity of N-terminal lipidated and/or fluorescently labeled conjugates of astressin as corticotropin releasing factor antagonists.
    Rijkers DT; den Hartog JA; Liskamp RM
    Bioorg Med Chem; 2004 Oct; 12(19):5099-106. PubMed ID: 15351393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of a 37-residue peptide amide corresponding to the entire amino acid sequence of alpha-form of rat calcitonin gene-related peptide (alpha-rCGRP).
    Ando K; Kitagawa K; Kiyama S; Kawamoto T; Akita T; Yamamoto I; Torizuka K
    Chem Pharm Bull (Tokyo); 1987 Jan; 35(1):60-71. PubMed ID: 3496172
    [No Abstract]   [Full Text] [Related]  

  • 13. Convulsant peptides related to corticotropin-releasing factor (CRF).
    Nomizu M; Miyamoto M
    Brain Res; 1989 Dec; 505(2):326-8. PubMed ID: 2598051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ligand requirements of the human corticotropin-releasing factor-binding protein.
    Sutton SW; Behan DP; Lahrichi SL; Kaiser R; Corrigan A; Lowry P; Potter E; Perrin MH; Rivier J; Vale WW
    Endocrinology; 1995 Mar; 136(3):1097-102. PubMed ID: 7867564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of amino acids in the N-terminal domain of corticotropin-releasing factor receptor 1 that are important determinants of high-affinity ligand binding.
    Wille S; Sydow S; Palchaudhuri MR; Spiess J; Dautzenberg FM
    J Neurochem; 1999 Jan; 72(1):388-95. PubMed ID: 9886092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants of corticotropin releasing factor. Receptor selectivity of corticotropin releasing factor related peptides.
    Mazur AW; Wang F; Tscheiner M; Donnelly E; Isfort RJ
    J Med Chem; 2004 Jun; 47(13):3450-4. PubMed ID: 15189041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solid phase synthesis of ovine corticotropin releasing factor.
    Morell JL; Brown JH
    Int J Pept Protein Res; 1985 Jul; 26(1):49-54. PubMed ID: 3877009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minimal-size, constrained corticotropin-releasing factor agonists with i-(i+3) Glu-Lys and Lys-Glu bridges.
    Rivier J; Lahrichi SL; Gulyas J; Erchegyi J; Koerber SC; Craig AG; Corrigan A; Rivier C; Vale W
    J Med Chem; 1998 Jul; 41(14):2614-20. PubMed ID: 9651165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Atrial natriuretic peptides. I. Synthesis of C-terminal fragments].
    Ovchinnikov MV; Bespalova ZhD; Molokoedov AS; Revenko IV; Sepetov NF
    Bioorg Khim; 1988 Jun; 14(6):759-67. PubMed ID: 2973326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Atrial natriuretic peptides. II. Synthesis of N-terminal fragments].
    Ovchinnikov MV; Bespalova ZhD; Molokoedov AS; Revenko IV; Sepetov NF
    Bioorg Khim; 1988 Jun; 14(6):768-76. PubMed ID: 2973327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.